The invention relates to a new strain, Lactobacillus helveticus LBK-16
H, DSM 13137, and a bacterial preparation containing the same. The new strain Lactobacillus
helveticus LBK-16 H has proteolytic activity and is capable of promoting the
production of nitric oxide, and thus it is useful both as a starter bacterium in
dairy industry and as a therapeutic substance as such and in various health-promoting
products and pharmaceuticals.
